Atlas Trials

Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction

Clinical trial NCT06469060 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06469060
Sponsor
Shanghai Chest Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2024-06-19
Primary completion
2025-06-30
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.